Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Cardona

Showing results (211-220 of 333) with videos related to

Pageof 34
Sort By:
Cancer Biomarkers : Section a of Disease Markers|May 31, 2021
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIsOscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín, et al.
Clinical Lung Cancer|May 5, 2021
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung CancerOscar Arrieta, Edgar Varela-Santoyo, Andrés F Cardona, et al.
The Oncologist|October 19, 2024
Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countriesOscar Arrieta, Maritza Ramos-Ramírez, Homero Garcés-Flores, et al.
JAMA Oncology|January 11, 2024
Mirtazapine as Appetite Stimulant in Patients With Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical TrialOscar Arrieta, Daniela Cárdenas-Fernández, Oscar Rodriguez-Mayoral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Response Assessment of <sup>68</sup>Ga-DOTA-E-[c(RGDfK)]<sup>2</sup> PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus DocetaxelOscar Arrieta, Francisco O Garcia-Perez, David Michel-Tello, et al.
Thoracic Cancer|February 20, 2020
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation statusOscar Arrieta, Laura-Alejandra Ramírez-Tirado, Enrique Caballé-Perez, et al.
Cognition|March 6, 2014
How embodied is action language? Neurological evidence from motor diseasesJuan F Cardona, Lucila Kargieman, Vladimiro Sinay, et al.
Scientific Reports|February 10, 2022
Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patientsOscar Arrieta, Camilo Molina-Romero, Fernanda Cornejo-Granados, et al.
Clinical Lung Cancer|February 4, 2025
Elucidating the Role of EGFR<sup>L858R</sup> in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI TherapyEduardo Rios-Garcia, Alberto Guijosa, Enrique Caballé-Perez, et al.
Cancer Treatment and Research Communications|April 17, 2026
Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort studyEnrique Caballé-Pérez, Luis Cabrera-Miranda, David Dávila-Dupont, et al.
Pageof 34

Showing results (211-220 of 333) with videos related to

Sort By:
Pageof 34
Cancer Biomarkers : Section a of Disease Markers|May 31, 2021
Impact of detecting plasma EGFR mutations with ultrasensitive liquid biopsy in outcomes of NSCLC patients treated with first- or second-generation EGFR-TKIsOscar Arrieta, Juan-Manuel Hernandez-Martinez, Edgar Montes-Servín, et al.
Clinical Lung Cancer|May 5, 2021
Association of Carcinoembryonic Antigen Reduction With Progression-free and Overall Survival Improvement in Advanced Non-small-cell Lung CancerOscar Arrieta, Edgar Varela-Santoyo, Andrés F Cardona, et al.
The Oncologist|October 19, 2024
Evaluation of a risk-sharing agreement for atezolizumab treatment in patients with non-small cell lung cancer: a strategy to improve access in low-income countriesOscar Arrieta, Maritza Ramos-Ramírez, Homero Garcés-Flores, et al.
JAMA Oncology|January 11, 2024
Mirtazapine as Appetite Stimulant in Patients With Non-Small Cell Lung Cancer and Anorexia: A Randomized Clinical TrialOscar Arrieta, Daniela Cárdenas-Fernández, Oscar Rodriguez-Mayoral, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Response Assessment of <sup>68</sup>Ga-DOTA-E-[c(RGDfK)]<sup>2</sup> PET/CT in Lung Adenocarcinoma Patients Treated with Nintedanib Plus DocetaxelOscar Arrieta, Francisco O Garcia-Perez, David Michel-Tello, et al.
Thoracic Cancer|February 20, 2020
Response rate of patients with baseline brain metastases from recently diagnosed non-small cell lung cancer receiving radiotherapy according to EGFR, ALK and KRAS mutation statusOscar Arrieta, Laura-Alejandra Ramírez-Tirado, Enrique Caballé-Perez, et al.
Cognition|March 6, 2014
How embodied is action language? Neurological evidence from motor diseasesJuan F Cardona, Lucila Kargieman, Vladimiro Sinay, et al.
Scientific Reports|February 10, 2022
Clinical and pathological characteristics associated with the presence of the IS6110 Mycobacterim tuberculosis transposon in neoplastic cells from non-small cell lung cancer patientsOscar Arrieta, Camilo Molina-Romero, Fernanda Cornejo-Granados, et al.
Clinical Lung Cancer|February 4, 2025
Elucidating the Role of EGFR<sup>L858R</sup> in Brain Metastasis Among Patients With Advanced NSCLC Undergoing TKI TherapyEduardo Rios-Garcia, Alberto Guijosa, Enrique Caballé-Perez, et al.
Cancer Treatment and Research Communications|April 17, 2026
Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort studyEnrique Caballé-Pérez, Luis Cabrera-Miranda, David Dávila-Dupont, et al.
Pageof 34